The Global Breast Cancer Brachytherapy Market was $63.10 Mn in 2020, and it is expected to reach $120.50 Mn by 2030. It is eventually growing at a commendable high compound of annual growth rate CAGR of 6.7% between 2020-2030, as per the latest market research report titled Global Breast Cancer Brachytherapy Market – Global industry analysis, size, share, growth, trends, and forecast, 2019-2030.
Download Free PDF Sample Request: https://www.sheeranalyticsandinsights.com/request-sample/breast-cancer-brachytherapy-market-21
Breast cancer is one of the most leading cause of mortality globally, especially in countries which are underdeveloped. As per the report of the international agency for cancer research, at present more than 15 million people are suffering from cancer. According to the experts, it is expected to reach 24 million by 2035. According to the American cancer society, in 2020, 79100 new breast cancer cases were detected, and around 42690 people died in U.S. only. Growing preference for the brachytherapy due to rising benefits compare to the other anti-cancer therapies are boosting the growth of breast cancer brachytherapy. Breast brachytherapy applied to the penitent who underwent breast-conserving surgery to give effective radiation to the tumor site.
Moreover, the current pandemic of the COVID-19 effect on the Breast Cancer Brachytherapy market. The growth rate graph changed slightly due to the pandemic situation. In the few last months, the rate of the patient visits hospital has reduced despite the OPD services and emergency cases. But it is expected that, after the pandemic of COVID-19, the market growth will reach a high position in the growth rate graph. Apart from that, the increasing healthcare centers across the world are anticipated to offer significant opportunities for market growth in the next forecast period of 2020 to 2030.
Geographically, The Breast Cancer Brachytherapy Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.
The report covers a detailed outlook of the company, and it includes the market share and company or industry profiles of key players operating in the global market. Key players in the report include Olympu, Eckert & Ziegler BEBIG, Elekta AB, Varian Medical Systems, Inc., ICAD, INC., Hologic, Inc., Cianna Medical, Arian Medical Systems, Inc. (US), C. R. Bard, Inc, Argon Medical Devices, Inc., IsoRay Medical, Inc., IsoAid, CIVCO Medical Solutions, Theragenics Corporation, and Arian Medical Systems, Inc. among others.
The Global Breast Cancer Brachytherapy Market Has Been Segmented into:
- High Dose Rate (HDR)
- Low Dose Rate (LDR)
- Pulse Dose Rate (PDR)
By Device Type
- After Loader
- Oncology Treatment Centers
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
Browse the full report at https://www.sheeranalyticsandinsights.com/market-report-research/breast-cancer-brachytherapy-market-21